MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance

MA Iqbal, S Arora, G Prakasam, GA Calin… - Molecular aspects of …, 2019 - Elsevier
Lung cancer is the cardinal cause of cancer-related deaths with restricted recourse of
therapy throughout the world. Clinical success of therapies is not very promising due to-late …

Systems biology of cisplatin resistance: past, present and future

L Galluzzi, I Vitale, J Michels, C Brenner… - Cell death & …, 2014 - nature.com
The platinum derivative cis-diamminedichloroplatinum (II), best known as cisplatin, is
currently employed for the clinical management of patients affected by testicular, ovarian …

[HTML][HTML] Decoding cell death signals in liver inflammation

C Brenner, L Galluzzi, O Kepp, G Kroemer - Journal of hepatology, 2013 - Elsevier
Inflammation can be either beneficial or detrimental to the liver, depending on multiple
factors. Mild (ie, limited in intensity and destined to resolve) inflammatory responses have …

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

M Michaud, I Martins, AQ Sukkurwala, S Adjemian… - Science, 2011 - science.org
Antineoplastic chemotherapies are particularly efficient when they elicit immunogenic cell
death, thus provoking an anticancer immune response. Here we demonstrate that …

Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators

M Ashrafizadeh, A Zarrabi, K Hushmandi, F Hashemi… - Cellular signalling, 2021 - Elsevier
Cisplatin (CP) is a well-known chemotherapeutic agent with excellent clinical effects. The
anti-tumor activity of CP has been demonstrated in different cancers such as breast, cervical …

MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy

AL Kasinski, FJ Slack - Nature Reviews Cancer, 2011 - nature.com
In normal cells multiple microRNAs (miRNAs) converge to maintain a proper balance of
various processes, including proliferation, differentiation and cell death. miRNA …

Molecular mechanisms of ATP secretion during immunogenic cell death

I Martins, Y Wang, M Michaud, Y Ma… - Cell Death & …, 2014 - nature.com
The immunogenic demise of cancer cells can be induced by various chemotherapeutics,
such as anthracyclines and oxaliplatin, and provokes an immune response against tumor …

Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition

M Bonora, A Bononi, E De Marchi, C Giorgi… - Cell cycle, 2013 - Taylor & Francis
The term “mitochondrial permeability transition”(MPT) refers to an abrupt increase in the
permeability of the inner mitochondrial membrane to low molecular weight solutes. Due to …

Cell death assays for drug discovery

O Kepp, L Galluzzi, M Lipinski, J Yuan… - Nature reviews Drug …, 2011 - nature.com
Cell death has an important role in many human diseases, and strategies aimed at
modulating the associated pathways have been successfully applied to treat various …

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

J Pol, E Vacchelli, F Aranda, F Castoldi… - …, 2015 - Taylor & Francis
The term “immunogenic cell death”(ICD) is now employed to indicate a functionally peculiar
form of apoptosis that is sufficient for immunocompetent hosts to mount an adaptive immune …